Lipiodol accumulation and transarterial chemoembolization efficacy for HCC patients

Hepato-Gastroenterology

Volumn 59, Issue 113, 2012, Pages 219-223

  Kawaguchi, Tsukasa ^a   Ohkawa, Kazuyoshi ^a   Imanaka, Kazuho ^a   Tamai, Chie ^a   Kawada, Natsuko ^a   Ikezawa, Kenji ^a   Uehara, Hiroyuki ^a   Itou, Yasushi ^a   Nakanishi, Katsuyuki ^a   Katayama, Kazuhiro ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Disease free survival (DFS); Hepatocellular carcinoma (HCC); Lipiodol accumulation pattern; Local recurrence rate; Transarterial chemoembolization (TACE)

Indexed keywords

IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THERAPY EFFECT;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE-FREE SURVIVAL; ETHIODIZED OIL; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84858170372     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11258     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108. (Pubitemid 40372904)
2. Bruix J, Llovet JM, Castells A, et al.: Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27:1578-83.
3. Llovet JM, Real MI, Montaña X, et al.: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734-9. (Pubitemid 34607087)
4. Lo CM, Ngan H, Tso WK, et al.: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-71. (Pubitemid 34454013)
5. Takayasu K, Arii S, Ikai I, et al.: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131:461-9. (Pubitemid 44142456)
6. Nishimine K, Uchida H, Matsuo N, et al.: Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for non-resectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 1994; 33:60-8.
7. Mazzaferro V, Regalia E, Doci R, et al.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-9. (Pubitemid 26079803)
8. Higuchi T, Kikuchi M, Okazaki M: Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer 1994; 73:2259-67. (Pubitemid 24129106)
9. Mirici-Cappa F, Gramenzi A, Santi V, et al.: Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 2010; 59:387-96.
10. Tateishi R, Shiina S, Teratani T, et al.: Percutaneous radiofrequency ablation for hepatocellular carcinoma: An analysis of 1000 cases. Cancer 2005; 103:1201-9. (Pubitemid 40328091)
11. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4cm. Gastroenterology 2004; 127:1714-23.
12. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3cm or less. Gut 2005; 54:1151-56.
13. Lencioni RA, Allgaier HP, Cioni D, et al.: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235-40. (Pubitemid 36736097)
14. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232:381-91.
15. N'Kontchou G, Mahamoudi A, Aout M, et al.: Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009; 50:1475-83.
16. Arii S, Yamaoka Y, Futagawa S, et al.: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000; 32:1224-9.
17. Ishii H, Okada S, Nose H, et al.: Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996; 77:1792-6. (Pubitemid 26125178)
18. Marelli L, Stigliano R, Triantes C, et al.: Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev 2006; 32:594-606. (Pubitemid 44645026)